Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

Theodore J. Robnett1, Mitchell Machtay, Eugenio Vinés, Michael G. McKenna, Kenneth Algazy, W. Gillies McKenna
1Hospital of the University of Pennyslvania, Philadelphia, PA, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Byhardt, 1995, The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer, Int J Radiat Oncol Biol Phys, 32, 1513, 10.1016/0360-3016(95)00084-C

Komaki, 1985, Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung, Am J Clin Oncol, 8, 362, 10.1097/00000421-198510000-00005

ASCO Clinical practice guidelines for the treatment of unresectable non–small-cell lung cancer. J Clin Oncol 1997;15:2996–3018.

AJCC American Joint Committee on Cancer (AJCC) cancer staging manual. Philadelphia: Lippincott-Raven; 1997.

Bonomi, 1996, Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non–small cell lung cancer, Semin Oncol, 6, 102

Furuse, 1997, Phase II study of 3-hour infusion paclitaxel in patients with previously untreated stage III and IV non–small cell lung cancer, Oncol, 54, 298, 10.1159/000227707

Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Belmont: Duxbury Press; 1988. p. 512–516.

Byhardt, 1993, The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non–small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 27, 537, 10.1016/0360-3016(93)90377-8

Gillam, 1964, Chronic bronchitis and radiotherapy of the lung, Lancet, 1, 1245, 10.1016/S0140-6736(64)91870-7

Hellman, 1964, Sequelae of radical radiotherapy of carcinoma of the lung, Radiology, 82, 1055, 10.1148/82.6.1055

Perez, 1980, A prospective study of various radiation doses and fractionation schedules in the treatment of inoperable non–oat-cell carcinoma of the lung, Cancer, 45, 2744, 10.1002/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U

Sherman, 1982, The effect of dose rate and Adriamycin on the tolerance of thoracic radiation in mice, Int J Radiat Oncol Biol Phys, 8, 45, 10.1016/0360-3016(82)90383-2

vonderMasse H, Overgaard J, Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 1986;5:245–257.

Byhardt, 1998, Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small cell carcinoma of the lung, Int J Radiat Oncol Biol Phys, 42, 469, 10.1016/S0360-3016(98)00251-X

Jeremic, 1996, Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non–small cell lung cancer, J Clin Oncol, 14, 1065, 10.1200/JCO.1996.14.4.1065

Schaake-Konig, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non–small cell lung cancer, N Engl J Med, 326, 524, 10.1056/NEJM199202203260805

Dillman, 1990, A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non–small cell lung cancer, N Engl J Med, 323, 940, 10.1056/NEJM199010043231403

Roberts, 1993, Radiation pneumonitis, Ann Intern Med, 118, 696, 10.7326/0003-4819-118-9-199305010-00006

Morgan, 1995, Radiation and the lung, Int J Radiat Oncol Biol Phys, 31, 361, 10.1016/0360-3016(94)00477-3

Choi, 1985, Physiologic changes in pulmonary function after thoracic radiotherapy for lung cancer and the role of regional pulmonary function studies in predicting post-radiotherapy pulmonary function, Cancer Treatment Symposia, 2, 119

Roach, 1995, Radiation pneumonitis following combined modality therapy for lung cancer, J Clin Oncol, 13, 2606, 10.1200/JCO.1995.13.10.2606

Armstrong, 1995, Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer, Ann Oncol, 6, 693, 10.1093/oxfordjournals.annonc.a059286

Graham, 1996, 3-D conformal radiotherapy for lung cancer, Front Radiat Ther Oncol, 29, 188, 10.1159/000424718

Kwa, 1998, Radiation pneumonitis as a function of mean lung dose, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5

Martel, 1994, DVH and 3-D treatment planning evaluation of patients with pneumonitits, Int J Radiat Oncol Biol Phys, 28, 575, 10.1016/0360-3016(94)90181-3

Robertson, 1997, Dose escalation for non–small cell lung cancer using conformal radiation therapy, Int J Radiat Oncol Biol Phys, 37, 1079, 10.1016/S0360-3016(96)00593-7